M&A

当事務所は、金融サービス、製造業、貿易、エネルギー・鉱業、自動車、不動産・建築、交通・運輸、ライフサイエンス・医療、食品・飲食業、カルチャー・エンターテイメント・スポーツ、電気通信、メディア及びハイテク等の幅広い産業における外資参入、国外投資、業界規制、国有資産管理、税務、外貨規制、知的財産、労働、独占禁止及び国家安全審査等の各分野の取扱い経験があります。

 

当事務所は中国M&A取引における数々の先例となる案件を処理してきました。

• In 2019, represented New Frontier Corporation to purchase United Family Healthcare (UFH) from TPG
• In 2019, represented Suning.com to acquire Carrefour China
• In 2019, represented Jiangxi Copper Company Limited's acquisition of the Canadian Listed Company First Quantum Minerals Ltd. Shares with a Consideration Exceeding USD 1.1 Billion
• In 2019, represented BeiGenes's Strategic Oncology Collaboration with Amgen
• In 2017, represented CNAC to acquire all the shares of Syngenta (listed in Switzerland and the U.S.) with a deal value of USD42.6 billion (the largest overseas investment acquisition project among Chinese companies, “Outbound Deal of the Year” by China Law & Practice 2017)
• In 2016, participated in IDG Capital's acquisition of shares of A shares listed company Sichuan Shuangma Cement Co., Ltd. and the takeover of control project
• In 2015, represented IFC regarding the strategic investment in Postal Savings Bank of China
• In 2014, represented HKEX-listed company Skyworth Digital Holdings Ltd. injected spin-off domestic STB business (estimated RMB3.5 billion) into China Resources Jinhua Co., Ltd. and listed domestically (The first case of back-door listing of overseas red chip listed company's spin-off domestic asset business at A shares securities market)
• In 2010, represented United Design Group on its overall consolidation with AsiaInfo (ASIA.Nasdaq) (The new company becomes the largest telecom software enterprise in China), and the afterwards listed in Hong Kong
• In 2009, represented Tianjin Port Development Holdings Limited (3382.HK), through its wholly-owned subsidiary Grand Point Investment Limited, acquired 56.81% shares in Tianjin Port Holdings Co., Ltd. (600717.SH) from Tianjin Port (Group) Co., Ltd. for a total consideration of HK$10,961 million (The first state-owned red chip company listed in Hong Kong to acquire the controlling interest in an A-share company listed in China by means of a reverse takeover)
• In 2002, represented SABMiller regarding its general offer to acquire Harbin Brewery Group Harbin Brewery (The first foreign general offer targeting Chinese companies on the Hong Kong Stock Exchange)
• Participated in the share swap absorption merger of Huabei Expressway (000916) and China Merchants Expressway Network & Technology Holdings Co., Ltd.
• Participated in Hubei Shalunda Co., Ltd. RMB18.4 billion share swap to acquire full stake in Adama Agricultural Solutions (the world's sixth-largest pesticide producer)

外部機構・団体からの評価

What the team is known for Well-established practice with expertise across a wide range of big-ticket M&A. Advises both multinational and domestic clients on onshore and cross-border deals, showing notable activity in the pharmaceutical, healthcare, mining and retail sectors. Active in cross-border transactions involving South-Eastern Asia and offshore jurisdictions.
——Chambers-Greater China Region 2022

 

The team are praised by a client for being "very hard-working." The same source remarks that "their service is also really great." Another source reports: "They are quite strong and we run into them often."
——Chambers-Greater China Region 2022

 

企業法務

当事務所は、企業法務について、設立から清算までの全過程の実務経験を豊富に有しています。同分野において主に下記の業務を取扱っています。

• 投資スキーム及びコーポレートガバナンススキームの提案
• 法務デューデリジェンス
• 商談・交渉への参加、会社設立関連文書の作成、レビュー、修正
• 各種行政手続サポート
• タックスプランニング、知財保護、労務管理、外貨、税関対応及び出口戦略等への助言
• 企業の日常運営における各種契約書の作成、レビュー及び交渉
• 訴訟及び仲裁に関するサポート
• 組織再編、決済及び清算等に関するサポート

外部機構・団体からの評価

What the team is known for  Well-regarded practice with notable experience in internal investigations, anti-bribery and antitrust matters. Utilising its expertise and advantage in the healthcare sphere, the team remains the popular choice among pharmaceutical companies. Also active in representing clients in the finance and logistics industries. Clients also benefit from its experience in responding to administrative investigations initiated by the Chinese authorities. Adept at advising on regulatory compliance issues and training.
——Chambers and Partners Asia-Pacific 2021

 

Well-established practice with expertise across a wide range of big-ticket M&A. Advises both multinational and domestic clients on onshore and cross-border deals, showing notable activity in the pharmaceutical and healthcare sectors. Also active on projects on behalf of clients in the mining industry. Increasingly active on transactions related to the Belt and Road Initiative.
——Chambers and Partners Asia-Pacific 2020

 

Strengths "They provide very, very practical advice. They're very pragmatic and able to give advice in layman's terms," states one client, who goes on to note that the firm offers "one-stop-shop service" and adds: "If employment issues crop up during the investigation or after the investigation, they can provide advice too."
——Chambers and Partners Asia-Pacific 2021

受賞歴

• 2022, Nominated in China Law Awards - Corporate M&A Law Firm of the Year, LEGALBAND
• 2021-2022, Nominated in Team of the Year - M&A, IFLR1000 China
• 2022, M&A (Inbound and domestic) Law Firm of the Year, China Business Law Journal
• 2022, Nominated in Regional Impact Deals: Shanghai - M&A - Shanghai Pharmaceuticals EUR18 million acquisition of Fimet Oy, IFLR1000 China
• 2022, Nominated in M&A Deal of the Year: East China: Primavera Capital Acquires Greater China Business of Mead Johnson from Reckitt Benckiser Group, Asian Legal Business
• 2021, Nominated in M&A Deal of the Year – Midsize: LuxsanTech’s acquisition of Two Subsidiaries of Wistron Corporation, Asian Legal Business
• 2020, Deals of The Year - M&A: “New Frontier Corporation in Acquisition of United Family Healthcare”, China Law & Practice
• 2020, Deal of the Year for Assisting Kazakhstan Boguty Tungsten Mine in its Equity and Debt Financing Project, China Business Law Journal
• 2019, Deals of the Year for NFC acquires United Family Healthcare, China Business Law Journal
• 2019, Deals of the Year for Suning acquires Carrefour China, China Business Law Journal
• 2020, M&A Deal of the Year – Midsize: “Carrefour's disposal of 80% equity stake in Carrefour China to Suning”, Asian Legal Business
• 2014, 2017-2020, Nominated in M&A Deal of the Year for several times, Asian Legal Business
• 2020, Nominated in M&A Deal of the Year – Midsize: “Jiangxi Copper Company Limited's acquisition of the Canadian Listed Company First Quantum Minerals Ltd. Shares with a Consideration Exceeding USD 1.1 Billion”, “New Frontier Corporation in Acquisition of United Family Healthcare” and “Carrefour's disposal of 80% equity stake in Carrefour China to Suning”, Asian Legal Business
• 2022, Nominated in M&A Deal of the Year: East China – Primavera Capital Acquires Greater China Business of Mead Johnson from Reckitt Benckiser Group, Asian Legal Business
• 2020, Nominated in M&A Deal of the Year – Premium: “BeiGenes's Strategic Oncology Collaboration With Amgen”, Asian Legal Business
• 2014-2016, Nominated in three consecutive years in M&A/Private Equity Law Firm of the Year, Asian Legal Business
• 2004-2013, Nominated in Recommended firm in M&A/Private, Asian Legal Business

Rankings

• 2022, Recommended firm in Corporate/M&A, Chambers and Partners Greater China Region
• 2012-2021, Recommended firm in Corporate/M&A, Chambers and Partners Asia Pacific
• 2019-2022, Recommended firm in Corporate/M&A, Chambers and Partners Global
• 2008-2011, Highly Recommended firm in Corporate and M&A, Chambers and Partners Asia Pacific
• 2011-2022, Recommended firm in Corporate and M&A, The Legal 500 Asia Pacific
• 2001-2010, Top-tier firm in Corporate and M&A, The Legal 500 Asia Pacific
• 2016-2021, The M&A Law Firm of the Year – China (band 2), Asian Legal Business
• 2022-2023, Highly Recommended firm in Corporate and M&A, Asialaw Profiles
• 2015-2021, Recommended firm in Corporate and M&A, Asialaw Profiles
• 2016-2023, Recommended firm in M&A, IFLR1000
• 2022-2023, Recommended firm in M&A (Beijing & Shanghai), IFLR1000 China
• 2016-2022, Top-tier firm in Corporate M&A, LEGALBAND
• 2022, Recommended firm: Beijing, Shanghai, Guangdong/Shenzhen, Sichuan/Chengdu - Commercial Disputes, (China Region Dispute Resolution List), Benchmark Litigation
• 2021, Recommended firm: Beijing, Shanghai, Shenzhen - Commercial and transactions (Benchmark Litigation China List), Benchmark Litigation
• 2020-2022, Recommended firm: Commercial and transactions (Asia-Pacific Dispute Resolution List), Benchmark Litigation
• 2020-2021, China Business Law Awards – “M & A (Outbound)”, China Business Law Journal
• 2010, Ranked eighth in the 2010 Asia-pacific Global Financial Advisory M&A Rankings and third in PRC firms (based on numbers of disclosed cases), Bloomberg Law